[Apropos of myasthenia gravis and its treatment].
D000549:Ambenonium Chloride / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000628:therapy; D009388:Neostigmine / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy; D013934:Thymectomy; D013945:Thymoma / Q000175:diagnosis; D013950:Thymus Gland; D013953:Thymus Neoplasms / Q000175:diagnosis; D014140:Tracheotomy
D007166:Immunosuppressive Agents; D009388:Neostigmine; D000549:Ambenonium Chloride; D011729:Pyridostigmine Bromide
A propos de la myasthénie grave et de son traitement.